Cakir S, Tasdelen Durak R, Ozyildirim I, Ince E, Sar V. Childhood trauma and treatment outcome in bipolar disorder. J Trauma Dissociation. 2016;17(4):397–409. https://doi.org/10.1080/15299732.2015.1132489.
Article
PubMed
Google Scholar
Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS. Scientific Advisory Board and the Executive Committee of the Grand Challenges on Global Mental Health, et al. Grand challenges in global mental health. Nature. 2011;475(7354):27–30. https://doi.org/10.1038/475027a.
Article
CAS
PubMed
PubMed Central
Google Scholar
Degenhardt EK, Gatz JL, Jacob J, Tohen M. Predictors of relapse or recurrence in bipolar I disorder. J Affect Disord. 2012;136(3):733–9. https://doi.org/10.1016/j.jad.2011.09.051.
Article
PubMed
Google Scholar
Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatr. 1997;58(11):470–8. https://doi.org/10.4088/jcp.v58n1102.
Article
CAS
Google Scholar
Etain B, Lajnef M, Brichant-Petitjean C, Geoffroy PA, Henry C, Gard S, Kahn JP, Leboyer M, Young AH, Bellivier F. Childhood trauma and mixed episodes are associated with poor response to lithium in bipolar disorders. Acta Psychiatr Scand. 2017;135(4):319–27. https://doi.org/10.1111/acps.12684.
Article
CAS
PubMed
Google Scholar
Garnham J, Munro A, Slaney C, Macdougall M, Passmore M, Duffy A, O’Donovan C, Teehan A, Alda M. Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study. J Affect Disord. 2007;104(1–3):185–90. https://doi.org/10.1016/j.jad.2007.03.003.
Article
PubMed
Google Scholar
Gasperini M, Scherillo P, Manfredonia MG, Franchini L, Smeraldi E. A study of relapses in subjects with mood disorder on lithium treatment ». Eur Neuropsychopharmacol. 1993;3(2):103–10.
Article
CAS
Google Scholar
Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes TRH, Cipriani A, Coghill DR, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition Recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30(6):495–553. https://doi.org/10.1177/0269881116636545.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gore FM, Bloem PJN, Patton GC, Ferguson J, Joseph V, Coffey C, Sawyer SM, Mathers CD. Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet. 2011;377(9783):2093–102. https://doi.org/10.1016/S0140-6736(11)60512-6.
Article
PubMed
Google Scholar
Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, MacDougall M, O’Donovan C, Alda M. Is response to prophylactic lithium a familial trait? J Clin Psychiatr. 2002;63(10):942–7.
Article
CAS
Google Scholar
Guloksuz S, Altinbas K, Aktas Cetin E, Kenis G, Bilgic Gazioglu S, Deniz G, Timucin Oral E, van Os J. Evidence for an association between Tumor Necrosis Factor-alpha levels and lithium response. J Affect Disord. 2012;143(1–3):148–52. https://doi.org/10.1016/j.jad.2012.04.044.
Article
CAS
PubMed
Google Scholar
Hui TP, Kandola A, Shen L, Lewis G, Osborn DPJ, Geddes JR, Hayes JF. A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder. Acta Psychiatr Scand. 2019;140(2):94–115. https://doi.org/10.1111/acps.13062.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kapur V, Nadella RK, Sathur Raghuraman B, Saraf G, Mishra S, Srinivasmurthy N, Jain S, Del Zompo M, Viswanath B. Clinical factors associated with lithium treatment response in bipolar disorder patients from India. Asian J Psychiatr. 2019;39:165–8. https://doi.org/10.1016/j.ajp.2018.04.006.
Article
PubMed
Google Scholar
Kato T, Inubushi T, Kato N. Prediction of lithium response by 31P-MRS in bipolar disorder. The International Journal of Neuropsychopharmacology. 2000;3(1):83–5. https://doi.org/10.1017/S1461145799001674.
Article
CAS
PubMed
Google Scholar
Kessing LV, Vradi E, Andersen PK. Nationwide and population-based prescription patterns in bipolar disorder. Bipolar Disord. 2016;18(2):174–82.
Article
CAS
Google Scholar
Kessing LV. Lithium as the drug of choice for maintenance treatment in bipolar disorder. Acta Psychiatr Scand. 2019;140(2):91–3. https://doi.org/10.1111/acps.13070.
Article
Google Scholar
Kessing LV, Bauer M, Nolen WA, Severus E, Goodwin GM, Geddes J. Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies. Bipolar Disord. 2018;20(5):419–31. https://doi.org/10.1111/bdi.12623.
Article
Google Scholar
Kessing LV, Hellmund G, Andersen PK. Predictors of excellent response to lithium: results from a nationwide register-based study. Int Clin Psychopharmacol. 2011;26(6):323–8. https://doi.org/10.1097/YIC.0b013e32834a5cd0.
Article
PubMed
Google Scholar
Kessing LV, Vradi E, Andersen PK. Starting lithium prophylaxis early v late in bipolar disorder. Br J Psychiatr. 2014;205(3):214–20. https://doi.org/10.1192/bjp.bp.113.142802.
Article
Google Scholar
Kessing LV, Vradi E, Andersen PK. Life expectancy in bipolar disorder. Bipolar Disord. 2015;17(5):543–8. https://doi.org/10.1111/bdi.12296.
Article
PubMed
Google Scholar
Kleindienst N, Engel R, Greil W. Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders. Bipolar Disord. 2005;7(5):404–17. https://doi.org/10.1111/j.1399-5618.2005.00244.x.
Article
CAS
PubMed
Google Scholar
Kulhara P, Basu D, Mattoo SK, Sharan P, Chopra R. Lithium prophylaxis of recurrent bipolar affective disorder: long-term outcome and its psychosocial correlates. J Affect Disord. 1999;54(1–2):87–96.
Article
CAS
Google Scholar
Kusalic M, Engelsmann F. Predictors of lithium treatment responsiveness in bipolar patients. A two-year prospective study. Neuropsychobiology. 1998;37(3):146–9. https://doi.org/10.1159/000026497.
Article
CAS
PubMed
Google Scholar
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. https://doi.org/10.1136/bmj.b2700.
Article
PubMed
PubMed Central
Google Scholar
Licht RW, Nielsen JN, Gram LF, Vestergaard P, Bendz H. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice The 6th trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord. 2010;12(5):483–93.
Article
CAS
Google Scholar
Maj M, Pirozzi R, Magliano L, Bartoli L. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Journal Psychiatr. 1998;155(1):30–5. https://doi.org/10.1176/ajp.155.1.30.
Article
CAS
Google Scholar
Maj M, Pirozzi R, Starace F. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. J Affect Disord. 1989;17(3):237–41.
Article
CAS
Google Scholar
Malhi GS, Outhred T, Morris G, Boyce PM, Bryant R, Fitzgerald PB, Hopwood MJ, et al. Royal Australian and New Zealand college of psychiatrists clinical practice guidelines for mood disorders: bipolar disorder summary. Medical J Australia. 2018;208(5):219–25.
Article
Google Scholar
Martinsson L, Wei Y, Xu D, Melas PA, Mathé AA, Schalling M, Lavebratt C, Backlund L. Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres. Translational Psychiatr. 2013;21(3):e261. https://doi.org/10.1038/tp.2013.37.
Article
CAS
Google Scholar
Masui T, Hashimoto R, Kusumi I, Suzuki K, Tanaka T, Nakagawa S, Suzuki T, et al. A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):204–8. https://doi.org/10.1016/j.pnpbp.2007.08.010.
Article
CAS
PubMed
Google Scholar
Miura T, Noma H, Furukawa TA, Mitsuyasu H, Tanaka S, Stockton S, Salanti G, et al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. Lancet Psychiatr. 2014;1(5):351–9. https://doi.org/10.1016/S2215-0366(14)70314-1.
Article
Google Scholar
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 Statement. Syst Rev. 2015;4:1. https://doi.org/10.1186/2046-4053-4-1.
Article
PubMed
PubMed Central
Google Scholar
Montlahuc C, Curis E, Grillault Laroche D, Bagoe G, Etain B, Bellivier F, Chevret S. Response to lithium in patients with bipolar disorder: what are psychiatrists’ experiences and practices compared to literature review? Pharmacopsychiatry. 2019;52(2):70–7. https://doi.org/10.1055/s-0044-100521.
Article
CAS
PubMed
Google Scholar
NIH Quality Assurance Guidelines. Study quality assessment tools, National Heart, Lung, and Blood Institute (NHLBI). 2019. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
Nolen WA, Licht RW, Young AH, Malhi GS, Tohen M, Vieta E, Kupka RW, Zarate C, Nielsen RE, Baldessarini RJ, Severus E. ISBD/IGSLI Task Force on the treatment with lithium What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium Version 2. Bipolar Disord. 2019;21(5):394–409. https://doi.org/10.1111/bdi.12805.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nunes A, Ardau R, Berghöfer A, Bocchetta A, Chillotti C, Deiana V, et al. Prediction of lithium response using clinical data. Acta Psychiatr Scand. 2020;141(2):131–41.
Article
CAS
Google Scholar
O’Connell RA, Mayo JA, Flatow L, Cuthbertson B, O’Brien BE. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatr. 1991;159:123–9. https://doi.org/10.1192/bjp.159.1.123.
Article
Google Scholar
Okuma T. Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology. 1993;27(3):138–45. https://doi.org/10.1159/000118969.
Article
CAS
PubMed
Google Scholar
Ozyildirim I, Cakir S, Yazici O. Impact of psychotic features on morbidity and course of illness in patients with bipolar disorder. European Psychiatry. 2010;25(1):47–51. https://doi.org/10.1016/j.eurpsy.2009.08.004.
Article
CAS
PubMed
Google Scholar
Passos IC, Ballester PL, Barros RC, Librenza-Garcia D, Mwangi B, Birmaher B, et al. Machine learning and big data analytics in bipolar disorder: a position paper from the International Society for Bipolar Disorders Big Data Task Force. Bipolar Disord. 2019;21(7):582–94.
Article
Google Scholar
Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2006;163(2):217–24.
Article
Google Scholar
Post RM, Leverich GS, Kupka R, Keck PE, McElroy SL, Altshuler LL, Frye MA, et al. Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder. Compr Psychiatry. 2016;66:146–56. https://doi.org/10.1016/j.comppsych.2016.01.009.
Article
PubMed
Google Scholar
Rybakowski JK. Factors Associated with Lithium Efficacy in Bipolar Disorder ». Harvard Rev Psychiatr. 2014;22(6):353–7. https://doi.org/10.1097/HRP.0000000000000006.
Article
Google Scholar
Rybakowski JK, Dembinska D, Kliwicki S, Akiskal KK, Akiskal HH. TEMPS-A and long-term lithium response: positive correlation with hyperthymic temperament. J Affect Disord. 2013;145(2):187–9. https://doi.org/10.1016/j.jad.2012.07.028.
Article
CAS
PubMed
Google Scholar
Rybakowski JK, Permoda-Osip A, Borkowska A. Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions. Eur Neuropsychopharmacol. 2009;19(11):791–5. https://doi.org/10.1016/j.euroneuro.2009.06.002.
Article
CAS
PubMed
Google Scholar
Rybakowski JK, Suwalska A, Skibinska M, DmitrzakWeglarz M, Leszczynska-Rodziewicz A, Hauser J. Response to lithium prophylaxis: interaction between serotonin transporter and BDNF Genes American Journal of Medical Genetics Part B. Neuropsychiatric Genetics. 2007;144B(6):820–3. https://doi.org/10.1002/ajmg.b.30420.
Article
CAS
PubMed
Google Scholar
Saito S, Fujii K, Ozeki Y, Ohmori K, Honda G, Mori H, Kato K, et al. Cognitive function, treatment response to lithium, and social functioning in Japanese patients with bipolar disorder. Bipolar Disord. 2017;19(7):552–62. https://doi.org/10.1111/bdi.12521.
Article
CAS
PubMed
Google Scholar
Schou M. Trends in lithium treatment and research during the last decade. Pharmacopsychiatria. 1982;15(4):128–30.
Article
CAS
Google Scholar
Scott J, Etain B, Bellivier F. Can an integrated science approach to precision medicine research improve lithium treatment in bipolar disorders? Frontiers Psychiatr. 2018;9:360. https://doi.org/10.3389/fpsyt.2018.00360.
Article
Google Scholar
Scott J, Geoffroy PA, Sportiche S, Brichant-PetitJean C, Gard S, Kahn JP, Azorin JM, Henry C, Etain B, Bellivier F. Cross-validation of clinical characteristics and treatment patterns associated with phenotypes for lithium response defined by the Alda scale. J Affect Disord. 2017;208:62–7. https://doi.org/10.1016/j.jad.2016.08.069.
Article
PubMed
Google Scholar
Scott J, Hidalgo-Mazzei D, Strawbridge R, Young AH, Resche-Rigon M, Etain B, Andreassen OA, et al. Prospective cohort study of early biosignatures of response to lithium in bipolar I disorders: overview of the H2020-funded R-LiNK initiative. Int J Bipolar Disord. 2019;7(1):20. https://doi.org/10.1186/s40345-019-0156-x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Severus E, Taylor MJ, Sauer C, Pfennig A, Ritter P, Bauer M, Geddes JR. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord. 2014;2:15. https://doi.org/10.1186/s40345-014-0015-8.
Article
PubMed
PubMed Central
Google Scholar
Shan GW, Makmor-Bakry M, Omar MS. Long term use of lithium and factors associated with treatment response among patients with bipolar disorder. Psychiatria Danubina. 2016;28(2):146–53.
CAS
PubMed
Google Scholar
Silva, LF, Cunha Loureiro J, Raposo Franco SC, de Lima Santos M, Secolin R, Lopes-Cendes I, de Rosalmeida Dantas C, et al. 2016. Assessing treatment response to prophylactic lithium use in patients with bipolar disorder. Jornal Brasileiro de Psiquiatria.2016;65 (1):9-16. https://doi.org/10.1590/0047-2085000000097.
Sportiche S, Geoffroy PA, Brichant-Petitjean C, Gard S, Khan JP, Azorin JM, Henry C, et al. Clinical factors associated with lithium response in bipolar disorders. Australian New Zealand J Psychiatr. 2017;51(5):524–30. https://doi.org/10.1177/0004867416664794.
Article
Google Scholar
Stefos G, Bauwens F, Staner L, Pardoen D, Mendlewicz J. Psychosocial predictors of major affective recurrences in bipolar disorder: a 4-year longitudinal study of patients on prophylactic treatment. Acta Psychiatr Scand. 1996;93(6):420–6. https://doi.org/10.1111/j.1600-0447.1996.tb10672.x.
Article
CAS
PubMed
Google Scholar
Tharoor H, Kotambail A, Jain S, Sharma PSVN, Satyamoorthy K. Study of the association of serotonin transporter triallelic 5-HTTLPR and STin2 VNTR polymorphisms with lithium prophylaxis response in bipolar disorder. Psychiatr Genet. 2013;23(2):77–81. https://doi.org/10.1097/YPG.0b013e32835d6fad.
Article
CAS
PubMed
Google Scholar
Thompson SG, Pocock SJ. Can meta-analyses be trusted? Lancet. 1991;338(8775):1127–30. https://doi.org/10.1016/0140-6736(91)91975-z.
Article
CAS
PubMed
Google Scholar
Tighe SK, Mahon B, Potash JB. Predictors of lithium response in bipolar disorder. Therapeutic AdvChronic Dis. 2011;2(3):209–26. https://doi.org/10.1177/2040622311399173.
Article
CAS
Google Scholar
Tondo L, Baldessarini RJ, Floris G. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders ». Br J Psychiatr. 2001;178(Suppl 41):S184–90.
Article
CAS
Google Scholar
Tondo L, Alda M, Bauer M, Bergink V, Grof P, Hajek T, Lewitka U, et al. Clinical use of lithium salts: guide for users and prescribers. Int J Bipolar Disord. 2019;7(1):16. https://doi.org/10.1186/s40345-019-0151-2.
Article
PubMed
PubMed Central
Google Scholar
Washizuka S, Ikeda A, Kato N, Kato T. Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder. Int J Neuropsychopharmacol. 2003;6(4):421–4. https://doi.org/10.1017/S1461145703003778.
Article
CAS
PubMed
Google Scholar
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 Guidelines for the Management of Patients with Bipolar Disorder. Bipolar Disord. 2018;20(2):97–170. https://doi.org/10.1111/bdi.12609.
Article
PubMed
PubMed Central
Google Scholar
Yazici O, Kora K, Uçok A, Tunali D, Turan N. Predictors of lithium prophylaxis in bipolar patients. J Affect Disord. 1999;55(2–3):133–42.
Article
CAS
Google Scholar